Bausch Health Companies Inc.
BHC.TO
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 6.13% | 12.16% | 10.86% | 10.77% | 9.87% |
| Total Other Revenue | 19.23% | 12.00% | 14.29% | 9.09% | 4.00% |
| Total Revenue | 6.27% | 12.15% | 10.89% | 10.75% | 9.80% |
| Cost of Revenue | 3.12% | 11.72% | 10.79% | 9.97% | 8.13% |
| Gross Profit | 7.57% | 12.32% | 10.94% | 11.09% | 10.51% |
| SG&A Expenses | 7.09% | 18.88% | 17.02% | 9.74% | 16.16% |
| Depreciation & Amortization | -8.16% | 8.30% | 0.37% | 0.37% | -9.90% |
| Other Operating Expenses | -- | -- | 200.00% | -- | -100.00% |
| Total Operating Expenses | 3.37% | 12.73% | 10.86% | 7.98% | 7.71% |
| Operating Income | 17.16% | 10.12% | 11.02% | 31.72% | 18.46% |
| Income Before Tax | 3,085.71% | 93.56% | -39.24% | 49.26% | 98.04% |
| Income Tax Expenses | 177.50% | 26.79% | -5.77% | -89.04% | -24.53% |
| Earnings from Continuing Operations | 308.51% | 75.92% | -103.70% | 63.16% | 88.54% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -162.50% | 75.00% | 1,200.00% | 62.50% | -- |
| Net Income | 338.46% | 77.51% | -61.54% | 68.16% | 90.49% |
| EBIT | 17.16% | 10.12% | 11.02% | 31.72% | 18.46% |
| EBITDA | 7.78% | 8.93% | 6.47% | 13.37% | 6.09% |
| EPS Basic | 327.27% | 77.70% | -61.85% | 68.46% | 90.27% |
| Normalized Basic EPS | 50.78% | 33.67% | 87.17% | 42.69% | 33.32% |
| EPS Diluted | 327.27% | 77.70% | -61.14% | 68.46% | 90.28% |
| Normalized Diluted EPS | 50.78% | 33.67% | 87.22% | 42.69% | 33.32% |
| Average Basic Shares Outstanding | 4.92% | 0.82% | 0.85% | 0.96% | -2.28% |
| Average Diluted Shares Outstanding | 4.92% | 0.82% | 0.84% | 0.96% | -2.28% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
